Abstract:We report here the design and synthesis of a series of 4-anilinoquinazoline derivatives, of which 7 compounds were crystallographically characterized, as epidermal growth factor receptor (EGFR) inhibitors by modifications on the aniline ring or at the 6-alkoxy site of the 6,7-dimethoxy-4-anilinoquinazoline pharmacophore. The relative inhibition efficiency on EGFR of all as-prepared compounds were measured and ordered, and the IC50 values of nine highly active compounds were determined by ELISA. Docking studies indicated that all 4-anilinoquinazoline derivatives could be inserted into the ATP-binding pocket of the EGFR via indirect docking, and that the modifications at the 3'-position of the anilino group and 6-alkoxy site of the quinazoline ring have little interference with the formation of the two essential H-bonds between the N3 of the quinazoline ring and Thr766 through a water molecule, and the N1 of the quinazoline ring and N-H of Met769. The displacing of the phenyl at 4-position with pyridinyl dramatically reduces the activity of the quinazoline pharmacophore, the resulting derivative (10) being the least active compound. The docking results also showed that the formation of new H-bonds between the N-H of the ethylenediamine group linked to the 6-alkoxy site and Asp776/Cys773 in the binding pocket of EGFR makes compounds 19 (IC50= 12.1 +/- 1.6 nM) and 20 (IC50 = 13.6 +/- 0.8 nM) the most potent EGFR inhibitors in this class and worthy of further modification to obtain more potent anticancer compounds. (C) 2012 Elsevier Masson SAS. All rights reserved.

Synthesis and Anti-Phosphorylation Activity of 4-Substitutedanilinoquinazoline Compounds

Synthesis and Bioactivities of 6,7,8-Trimethoxy-n-aryl-4-aminoquinazoline Derivatives

Synthesis and Antitumor Activity of Novel 4-Aminoquinazoline Derivatives Containing Benzothiazole

Synthesis and Anti‐Proliferation Activity Evaluation of Novel 2‐chloroquinazoline As Potential EGFR‐TK Inhibitors

Synthesis and antitumor activity evaluation in vitro of 4-aminoquinazoline derivatives containing 1,3,4-thiadiazole

Design, synthesis and anti-tumor activity evaluation of 4,6,7-substitute quinazoline derivatives

Synthesis and Anticancer Activities of 5,6,7-Trimethoxy-n-phenyl(ethyl)-4-aminoquinazoline Derivatives

Design, synthesis and biological evaluation of new 4-(4-substituted-anilino)quinoline derivatives as anticancer agents

Synthesis and bioactivity of 4-arylamino-6,7-dimethoxyl quinazoline derivatives

Synthesis and Antiproliferative Activity Studies on 2-Substitued Aniline Quinazoline Derivatives

Synthesis of New 4-Anilinoquinazoline Analogues and Evaluation of Their EGFR Inhibitor Activity.

Synthesis and Biological Evaluation of Novel Substituted 4‐anilinoquinazolines As Antitumor Agents

Synthesis and bioactivity of 4-alkyl(aryl)thioquinazoline derivatives.

Synthesis and Bioactivity of 6,7-Dimethoxy-quinazoline-4-arylamine Derivatives

Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives

Synthesis and Antitumor Activity Evaluation of 2,4,6-Trisubstituted Quinazoline Derivatives Containing Thiazole Structure

Synthesis, Characterization, Screening And Docking Analysis Of 4-Anilinoquinazoline Derivatives As Tyrosine Kinase Inhibitors

The synthesis and anti-tumor activity research of a novel quinazoline derivatives

Synthesis of 4-substituted-7-chloroquinoline derivatives and preliminary evaluation of their antitumor activity

Synthesis and Antitumor Activity of Novel Quinazoline Derivatives Containing Acrylamide

Synthesis, in Vitro and in Vivo Evaluation of Novel Substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines As Potent Antitumor Agents.